These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
138 related items for PubMed ID: 4076345
1. Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain. Trulson ME, Crisp T. Eur J Pharmacol; 1985 Nov 05; 117(2):267-70. PubMed ID: 4076345 [Abstract] [Full Text] [Related]
2. Chronic D-amphetamine and phencyclidine: effects on dopamine agonist and antagonist binding sites in the extrapyramidal and mesolimbic systems. Robertson HA. Brain Res; 1983 May 09; 267(1):179-82. PubMed ID: 6860944 [Abstract] [Full Text] [Related]
3. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine. Riffee WH, Wilcox RE, Vaughn DM, Smith RV. Psychopharmacology (Berl); 1982 May 09; 77(2):146-9. PubMed ID: 6812131 [Abstract] [Full Text] [Related]
4. Chronic phencyclidine, like amphetamine, produces a decrease in [3H]spiroperidol binding in rat striatum. Robertson HA. Eur J Pharmacol; 1982 Mar 12; 78(3):363-5. PubMed ID: 7067731 [Abstract] [Full Text] [Related]
5. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding. Sibley DR, Weinberger S, Segal DS, Creese I. Experientia; 1982 Oct 15; 38(10):1224-5. PubMed ID: 6890464 [No Abstract] [Full Text] [Related]
6. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury. Neve KA, Altar CA, Wong CA, Marshall JF. Brain Res; 1984 Jun 04; 302(1):9-18. PubMed ID: 6428705 [Abstract] [Full Text] [Related]
7. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes. Howlett DR, Nahorski SR. FEBS Lett; 1978 Mar 01; 87(1):152-6. PubMed ID: 631328 [No Abstract] [Full Text] [Related]
9. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release. Nielsen EB, Nielsen M, Braestrup C. Psychopharmacology (Berl); 1983 Mar 01; 81(1):81-5. PubMed ID: 6415736 [Abstract] [Full Text] [Related]
10. Effects of haloperidol and d-amphetamine on in vivo 3H-spiroperiodol binding in the rat forebrain(1). Saelens JK, Simke JP, Neale SE, Weeks BJ, Selwyn M. Arch Int Pharmacodyn Ther; 1980 Jul 01; 246(1):98-107. PubMed ID: 7447553 [Abstract] [Full Text] [Related]
11. Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation. Ellison G, Morris W. Eur J Pharmacol; 1981 Sep 11; 74(2-3):207-14. PubMed ID: 7198992 [Abstract] [Full Text] [Related]
12. The residual effect of chronic neuroleptic treatment on the neuroleptic binding assay in rats. Wan CW, Peck EJ, Ho BT, Schoolar JC. Life Sci; 1983 Mar 14; 32(11):1255-62. PubMed ID: 6834989 [Abstract] [Full Text] [Related]
14. Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity. Akiyama K, Sato M, Otsuki S. Biol Psychiatry; 1982 Feb 14; 17(2):223-31. PubMed ID: 7200378 [Abstract] [Full Text] [Related]
16. Decreased spiroperidol and LSD binding in rat brain after continuous amphetamine. Nielsen EB, Nielsen M, Ellison G, Braestrup C. Eur J Pharmacol; 1980 Aug 29; 66(2-3):149-54. PubMed ID: 7439269 [Abstract] [Full Text] [Related]
17. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components. Akiyama K, Sato M, Kashihara K, Otsuki S. Biol Psychiatry; 1982 Dec 29; 17(12):1389-402. PubMed ID: 7159638 [Abstract] [Full Text] [Related]
18. Chronic proglumide increases [3H]spiperone binding in the rat brain. Bean AJ, Baldy WJ, Martin GE. Eur J Pharmacol; 1985 Oct 29; 117(1):97-101. PubMed ID: 4085545 [Abstract] [Full Text] [Related]
19. Properties of dopamine agonist and antagonist binding sites in mammalian retina. Makman MH, Dvorkin B, Horowitz SG, Thal LJ. Brain Res; 1980 Aug 04; 194(2):403-18. PubMed ID: 6770965 [Abstract] [Full Text] [Related]